Cytomics and drug discovery

Pharmaceutical companies try to develop new drugs that have a high success rate of reaching the market. However, current disease models lack a strong correlation to clinical reality, because of the underestimation of the complexity and variability of clinical disease processes. This leads to high attrition rates late in drug development and soaring costs. Improvement of disease models is an important issue to reduce the high attrition rates in drug development. Using cell‐based disease models, which should take into account the molecular diversity of the human cytome, will improve the predictive value of drug discovery. © 2006 International Society for Analytical Cytology

[1]  David F. Horrobin,et al.  Modern biomedical research: an internally self-consistent universe with little contact with medical reality? , 2003, Nature Reviews Drug Discovery.

[2]  Chris Pollard,et al.  Comparative Pharmacology of Guinea Pig Cardiac Myocyte and Cloned hERG (IKr) Channel , 2004, Journal of cardiovascular electrophysiology.

[3]  A. Tárnok,et al.  Potential and challenges of a human cytome project. , 2004, Journal of biological regulators and homeostatic agents.

[4]  Terry Kenakin,et al.  A guide to drug discovery: Predicting therapeutic value in the lead optimization phase of drug discovery , 2003, Nature Reviews Drug Discovery.

[5]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[6]  Jason R Swedlow,et al.  To 5D and Beyond: Quantitative Fluorescence Microscopy in the Postgenomic Era , 2002, Traffic.

[7]  Lani F. Wu,et al.  Multidimensional Drug Profiling By Automated Microscopy , 2004, Science.

[8]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[9]  D. L. Taylor,et al.  High content screening applied to large-scale cell biology. , 2004, Trends in biotechnology.

[10]  Roger Y Tsien,et al.  Imagining imaging's future. , 2003, Nature reviews. Molecular cell biology.

[11]  Attila Tarnok,et al.  Cytomics in predictive medicine , 2003, SPIE BiOS.

[12]  R. Tuan,et al.  Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy , 2004, Journal of cellular and molecular medicine.

[13]  Robert F. Murphy,et al.  Location proteomics: building subcellular location trees from high-resolution 3D fluorescence microscope images of randomly tagged proteins , 2003, SPIE BiOS.

[14]  Ping Zhu,et al.  Regulation of nuclear translocation of nuclear factor-kappaB relA: evidence for complex dynamics at the single-cell level. , 2003, The Biochemical journal.

[15]  A Tárnok,et al.  Cytomics—New technologies: Towards a human cytome project , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.